CUX1, a haploinsufficient tumour suppressor gene overexpressed in advanced cancers

被引:91
作者
Ramdzan, Zubaidah M. [1 ]
Nepveu, Alain p [1 ,2 ,3 ,4 ]
机构
[1] McGill Univ, Goodman Canc Ctr, Montreal, PQ H3A 1A3, Canada
[2] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada
[3] McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada
[4] McGill Univ, Dept Oncol, Montreal, PQ H3A 1A3, Canada
基金
加拿大健康研究院;
关键词
CCAAT-DISPLACEMENT PROTEIN; FACTOR HINF-D; CDP/CUX TRANSCRIPTION FACTOR; CUT HOMEODOMAIN PROTEIN; CELL-BASED ASSAYS; TRANSGENIC MICE; S-PHASE; UTERINE LEIOMYOMAS; MYELOID-LEUKEMIA; DNA-BINDING;
D O I
10.1038/nrc3805
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CUT-like homeobox 1 (CUX1) is a homeobox gene that is implicated in both tumour suppression and progression. The accumulated evidence supports a model of haploinsufficiency whereby reduced CUM expression promotes tumour development. Paradoxically, increased CUX1 expression is associated with tumour progression, and ectopic CUX1 expression in transgenic mice increases tumour burden in several tissues. One CUX1 isoform functions as an ancillary factor in base excision repair and the other CUX1 isoforms act as transcriptional activators or repressors. Several transcriptional targets and cellular functions of CUX1 affect tumorigenesis; however, we have yet to develop a mechanistic framework to reconcile the opposite roles of CUX1 in cancer protection and progression.
引用
收藏
页码:673 / 682
页数:10
相关论文
共 85 条
[1]   A method and server for predicting damaging missense mutations [J].
Adzhubei, Ivan A. ;
Schmidt, Steffen ;
Peshkin, Leonid ;
Ramensky, Vasily E. ;
Gerasimova, Anna ;
Bork, Peer ;
Kondrashov, Alexey S. ;
Sunyaev, Shamil R. .
NATURE METHODS, 2010, 7 (04) :248-249
[2]   CUTL1 promotes tumor cell migration by decreasing proteasome-mediated Src degradation [J].
Aleksic, T. ;
Bechtel, M. ;
Krndija, D. ;
von Wichert, G. ;
Knobel, B. ;
Giehl, K. ;
Gress, T. M. ;
Michl, P. .
ONCOGENE, 2007, 26 (40) :5939-5949
[3]   PRIMARY STRUCTURE AND EXPRESSION OF A PRODUCT FROM CUT, A LOCUS INVOLVED IN SPECIFYING SENSORY ORGAN IDENTITY IN DROSOPHILA [J].
BLOCHLINGER, K ;
BODMER, R ;
JACK, J ;
JAN, LY ;
JAN, YN .
NATURE, 1988, 333 (6174) :629-635
[4]   Cux-1 transgenic mice develop glomerulosclerosis and interstitial fibrosis [J].
Brantley, JG ;
Sharma, M ;
Alcalay, NI ;
Vanden Heuvel, GB .
KIDNEY INTERNATIONAL, 2003, 63 (04) :1240-1248
[5]   Polycystic kidneys caused by sustained expression of Cux1 isoform p75 [J].
Cadieux, Chantal ;
Harada, Ryoko ;
Paquet, Marilene ;
Cote, Olivier ;
Trudel, Marie ;
Nepveu, Alain ;
Bouchard, Maxime .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (20) :13817-13824
[6]   Transgenic mice expressing the p75 CCAAT-displacement protein/cut homeobox isoform develop a myeloproliferative disease-like myeloid leukemia [J].
Cadieux, Chantal ;
Fournier, Sylvie ;
Peterson, Alan C. ;
Bedard, Christian ;
Bedell, Barry J. ;
Nepveu, Alain .
CANCER RESEARCH, 2006, 66 (19) :9492-9501
[7]   Mouse Mammary Tumor Virus p75 and p110 CUX1 Transgenic Mice Develop Mammary Tumors of Various Histologic Types [J].
Cadieux, Chantal ;
Kedinger, Valerie ;
Yao, Lu ;
Vadnais, Charles ;
Drossos, Maria ;
Paquet, Marilene ;
Nepveu, Alain .
CANCER RESEARCH, 2009, 69 (18) :7188-7197
[8]   Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse [J].
Collier, LS ;
Carlson, CM ;
Ravimohan, S ;
Dupuy, AJ ;
Largaespada, DA .
NATURE, 2005, 436 (7048) :272-276
[9]   The mammalian Cut homeodomain protein functions as a cell-cycle-dependent transcriptional repressor which downmodulates p21WAF1/CIP1/SDI1 in S phase [J].
Coqueret, O ;
Bérubé, G ;
Nepveu, A .
EMBO JOURNAL, 1998, 17 (16) :4680-4694
[10]   Cux1 and Cux2 Regulate Dendritic Branching, Spine Morphology, and Synapses of the Upper Layer Neurons of the Cortex [J].
Cubelos, Beatriz ;
Sebastian-Serrano, Alvaro ;
Beccari, Leonardo ;
Elisa Calcagnotto, Maria ;
Cisneros, Elsa ;
Kim, Seonhee ;
Dopazo, Ana ;
Alvarez-Dolado, Manuel ;
Miguel Redondo, Juan ;
Bovolenta, Paola ;
Walsh, Christopher A. ;
Nieto, Marta .
NEURON, 2010, 66 (04) :523-535